Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D05QPC
|
|||
| Former ID |
DIB015238
|
|||
| Drug Name |
[L/D]-aminopterin
|
|||
| Indication | Rheumatoid arthritis [ICD-11: FA20] | Phase 2 | [1], [2] | |
| Company |
Syntrix biosystems
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | LD-aminopterin in the canine homologue of human atopic dermatitis: a randomized, controlled trial reveals dosing factors affecting optimal therapy. PLoS One. 2014 Sep 25;9(9):e108303. | |||
| REF 2 | ClinicalTrials.gov (NCT01724931) Aminopterin Dose Finding Treatment for Methotrexate-Naive Rheumatoid Arthritis. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.